Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)
Clinical trial NCT04439188 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439188
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-21
- Primary completion
- 2020-11-10
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.